Zachary Scheiner
Director · LENZ Therapeutics, Inc.
Individual
- 2026
- Jun 16, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Zachary Scheiner files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- RA CAPITAL MANAGEMENT, L.P. - $59.04M in SGP purchases and sales in the last 12 months
- Anthony A. Florence Jr. - $15.00M in SGP purchases and sales in the last 12 months
- Edward T. Mathers - $15.00M in SGP purchases and sales in the last 12 months
- Paul Edward Walker - $15.00M in SGP purchases and sales in the last 12 months
- Forest Baskett - $15.00M in SGP purchases and sales in the last 12 months
- Scott D. Sandell - $15.00M in SGP purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Zachary Scheiner?
Zachary Scheiner is a corporate insider, tracked as Director of LENZ Therapeutics, Inc. (LENZ). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Zachary Scheiner last file a Form 4?
The most recent primary Form 4 on record is dated 16 June 2026, one of 3 filings going back to 2026.
